Mindfulness-based Intervention for Teenagers With Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01783418 |
|
Recruitment Status :
Completed
First Posted : February 4, 2013
Results First Posted : January 12, 2016
Last Update Posted : January 12, 2016
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Pediatric Cancer | Behavioral: Mindfulness Intervention | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 15 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Participant) |
| Primary Purpose: | Supportive Care |
| Official Title: | A Randomized, Wait-list Controlled Clinical Trial: the Effects of a Mindfulness-based Intervention on Quality of Life, Sleep and Mood in Adolescents With Cancer. |
| Study Start Date : | August 2012 |
| Actual Primary Completion Date : | September 2014 |
| Actual Study Completion Date : | September 2014 |
| Arm | Intervention/treatment |
|---|---|
| Experimental: Mindfulness intervention |
Behavioral: Mindfulness Intervention
Mindfulness-based intervention adapted for teenagers |
| Active Comparator: Wait-list control |
Behavioral: Mindfulness Intervention
Mindfulness-based intervention adapted for teenagers |
- Changes in Mood From Baseline to Post-intervention and 6 Months Post-intervention [ Time Frame: Baseline, Post-intervention (8 weeks) ]
Beck Youth Inventory - Anxiety scale Subscale range: 0 (minimum score) - 60 (maximum score)
Higher scores indicate higher anxiety and a worse outcome
- Changes in Quality of Life From Baseline to Post-intervention and 6 Months Post-intervention [ Time Frame: Baseline, Post-intervention (8 weeks) ]
Pediatric Cancer Quality of Life Inventory
Scale range: 0 (minimum score) to 108 (maximum score) Higher scores represent better outcomes
- Changes Sleep From Baseline to Post-intervention and 6 Months Post-intervention [ Time Frame: Baseline, Post-intervention (8 weeks) ]
Pittsburgh Sleep Quality Index
Score range: 0 (minimum score) - 21 (maximum score)
Higher scores indicate worse outcomes
- Changes in Mood From Baseline to Post-intervention and 6 Months Post-intervention [ Time Frame: baseline, Post-intervention (8 weeks) ]
Beck youth inventories - Depression scale
Subscale range: 0 (minimum score) - 60 (maximum score)
Higher scores a worse outcome
- Changes in Mood From Baseline to Post-intervention and 6 Months Post-intervention [ Time Frame: baseline, Post-intervention (8 weeks) ]
PANAS-C - Positive affect
Score range: 0 (minimum score) - 50 (maximum score)
High scores represent better outcomes
- Changes in Mood From Baseline to Post-intervention and 6 Months Post-intervention [ Time Frame: Baseline, Post-intervention (8 weeks) ]
PANAS-C - Negative affect
Score range: 0 (minimum score) - 50 (maximum score) Higher scores represent worse outcomes
- Changes in Mindfulness Propensity and Skills From Baseline to Post-intervention and 6 Months Post-intervention [ Time Frame: Baseline, Post-intervention (8 weeks) ]
Children and Adolescent Mindfulness Measure Score range: 0 (minimum score) - 40 (maximum score)
Higher scores represent better outcomes
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 12 Years to 18 Years (Child, Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Teenagers (ages 12-18) with cancer
Exclusion Criteria:
- No ongoing or lifetime severe psychopathology, such as schizophrenia, psychosis, delusional disorders or organic mental disorders
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01783418
| Canada, Quebec | |
| CHU Sainte-Justine, Mother and Child University Hospital Center | |
| Montreal, Quebec, Canada, H3T 1C5 | |
| Principal Investigator: | Catherine Malboeuf-Hurtubise, Ph.D. candidate | Université de Montréal | |
| Study Director: | Marie Achille, Ph.D. | Université de Montréal | |
| Study Director: | Serge Sultan, Ph.D. | Université de Montréal, St. Justine's Hospital | |
| Study Director: | Majorie Vadnais, M.D. | St. Justine's Hospital |
| Responsible Party: | Catherine Malboeuf-Hurtubise, Ph.D. Candidate, clinical psychology, Université de Montréal, St. Justine's Hospital |
| ClinicalTrials.gov Identifier: | NCT01783418 |
| Other Study ID Numbers: |
3550 |
| First Posted: | February 4, 2013 Key Record Dates |
| Results First Posted: | January 12, 2016 |
| Last Update Posted: | January 12, 2016 |
| Last Verified: | December 2015 |
|
mindfulness-based meditation pediatric cancer adolescence quality of life |
sleep affect health psychology |

